Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

Philippines receives its first AztraZeneca vaccines under COVAX

Published 03/04/2021, 09:01 PM
Updated 03/04/2021, 09:10 PM
© Reuters
AZN
-
AZN
-

MANILA, March 4 (Reuters) - The Philippines has received its
first delivery of the AstraZeneca (NASDAQ:AZN) AZN.L COVID-19 shots,
secured through the vaccine-sharing COVAX facility, its health
ministry said on Thursday.
The country hopes to get a total of 4.58 million doses of
AstraZeneca shots via COVAX by May, and the newly arrived
487,200 doses are the initial shipment.
The first batch of AstraZeneca doses will add to the
Southeast Asian country's stock of 600,0000 Sinovac vaccines
that China donated, and which Manila used to launch its
inoculation campaign on Monday. "With every dose that we will administer, we are inching
towards a safer recovery from this pandemic," Health Secretary
Francisco Duque said in a statement.
President Rodrigo Duterte has said he would lift
restrictions on businesses and public transport in the capital
Manila once his government has secured 20 to 40 million doses of
COVID-19 shots.
The Philippines, which is battling one of the worst
coronavirus outbreaks in Asia, has reported more than 580,000
COVID-19 cases overall, including infections caused by the
British and South African variants. It has recorded more than
12,404 deaths.
It aims this year to inoculate 70 million of its 108 million
people to achieve herd immunity and reopen an economy that in
2020 saw its worst contraction on record, due largely to tight
restrictions on movement in place since mid-March.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.